# reload+after+2024-01-20 21:35:25.719522
address1§Dominion Way
city§Worthing
zip§BN14 8SA
country§United Kingdom
phone§44 1903 844 700
website§https://www.allergytherapeutics.com
industry§Drug Manufacturers - Specialty & Generic
industryKey§drug-manufacturers-specialty-generic
industryDisp§Drug Manufacturers - Specialty & Generic
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Manuel  Llobet', 'age': 59, 'title': 'CEO & Executive Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 379383, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Shaun  Furlong', 'title': 'Chief Financial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Beverly  Lees', 'title': 'Group Operations Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Murray  Skinner', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Santiago  Puig', 'title': 'Business Development Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sue  Baker', 'title': 'Head of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Simon  Piggott', 'title': 'Head of Clinical Science', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Alan  Bullimore', 'title': 'Head of Communication & Market Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Russell  Picket', 'title': 'Group Financial Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Karley Charlotte Mouatt Cheesman', 'title': 'Company Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.277
priceToSalesTrailing12Months§1.9549973
currency§GBp
forwardEps§0.0
exchange§LSE
quoteType§EQUITY
shortName§ALLERGY THERAPEUTICS PLC ORD 0.
longName§Allergy Therapeutics plc
firstTradeDateEpochUtc§1097478000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§873d0d30-f373-35e3-b55e-be89ef3d0105
messageBoardId§finmb_1789203
targetHighPrice§16.11
targetLowPrice§16.11
targetMeanPrice§16.11
targetMedianPrice§16.11
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§1.044
grossMargins§0.56782
ebitdaMargins§-0.48407
trailingPegRatio§None
